Escape from Immune Surveillance by Capnocytophaga canimorsus by Shin, Hwain et al.
Escape from Immune Surveillance by C. canimorsus • JID 2007:195 (1 February) • 375
M A J O R A R T I C L E
Escape from Immune Surveillance
by Capnocytophaga canimorsus
Hwain Shin, Manuela Mally, Marina Kuhn, Cecile Paroz, and Guy R. Cornelis
Biozentrum, University of Basel, Basel, Switzerland
Capnocytophaga canimorsus, a commensal bacterium from dogs’ mouths, can cause septicemia or meningitis
in humans through bites or scratches. Here, we describe and characterize the inflammatory response of human
and mouse macrophages on C. canimorsus infection. Macrophages infected with 10 different strains failed to
release tumor necrosis factor (TNF)–a and interleukin (IL)–1a. Macrophages infected with live and heat-killed
(HK) C. canimorsus 5 (Cc5), a strain isolated from a patient with fatal septicemia, did not release IL-6, IL-8,
interferon-g, macrophage inflammatory protein–1b, and nitric oxide (NO). This absence of a proinflammatory
response was characterized by the inability of Toll-like receptor (TLR) 4 to respond to Cc5. Moreover, live
but not HK Cc5 blocked the release of TNF-a and NO induced by HK Yersinia enterocolitica. In addition,
live Cc5 down-regulated the expression of TLR4 and dephosphorylated p38 mitogen-activated protein kinase.
These results highlight passive and active mechanisms of immune evasion by C. canimorsus, which may explain
its capacity to escape from the host immune system.
Millions of people are bitten by dogs every year, but
only 5%–10% of dog bites become infected. The overall
mortality of such infections is around 6 deaths out of
100 million population annually in the United States
[1, 2]. However, since 1976, there have been numerous
case reports describing sepsis or meningitis after dog
bites. Bacteria isolated from these dramatic cases were
found to belong to a new species, which was later called
Capnocytophaga canimorsus [3].
The genus Capnocytophaga contains 7 species, all of
them encountered in the oral cavity of humans or do-
mestic animals. But C. canimorsus, commonly found
in dogs, is the only one associated with severe human
infections [4]. The genus Capnocytophaga belongs to
the class of Flavobacteria. Flavobacteria in turn belong
to the Bacteroidetes phylum, which includes various
species of Bacteroides and Porphyromonas gingivalis [5,
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6]. In the bacterial evolutionary tree, the Bacteroidetes
phylum is very remote from proteobacteria and the com-
mon human pathogens. Although substantial knowledge
on the metabolism and genetics of Bacteroides species
exists, much less is known about Flavobacteria and es-
pecially about Capnocytophaga species.
More than 160 cases of severe infections with C.
canimorsus have been reported in the literature. Patients
infected with C. canimorsus have been bitten, scratched,
or sometimes simply licked by a dog or occasionally
by a cat. Symptoms usually appear after 2–3 days, and
patients are generally admitted to the hospital several
days after the exposure, with symptoms of sepsis or
meningitis. Mortality is as high as 30% for septicemia,
but it is only around 5% for meningitis [7]. Many of
these infections involve patients who have had a sple-
nectomy, are alcoholic, or are immunocompromised,
but a significant number involve healthy people with
no obvious risk factors [8–11]. C. canimorsus is thus
an emerging pathogen, and cannot be considered sim-
ply as an opportunistic bacterium. Little is known about
the pathogenesis of infection with C. canimorsus. It has
been reported to multiply in J774.1 mouse macrophages
and to be cytotoxic, presumably by secreting a toxin
[12]. More studies have been devoted to C. ochracea,
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which is an agent of periodontal disease and has been report-
ed to degrade lactoferrin [13], IgG [14], and IgA [15] and to
produce an immunosuppressive factor [16]. In addition, the
lipopolysaccharide (LPS) from C. ochracea has been shown to
be an antagonist for human Toll-like receptor (TLR) 4 [17].
The overall clinical evolution of C. canimorsus infections
suggests that the bacterium elicits little inflammation, at least
in the early stages of the infection, which would allow time for
multiplication, up to a stage at which it causes general sepsis
and a deadly shock. In some cases, the patient even died of a
secondary aspergillosis, suggesting that C. canimorsus might
have induced some immunodeficiency (J. B. le Polain, personal
communication). In this article, we test this hypothesis, and
we show that indeed C. canimorsus does not elicit inflammation
and that at least 2 different mechanisms contribute to this effect.
MATERIALS AND METHODS
Bacterial strains and identification. The strains of C. cani-
morsus are listed in table 1. The identity of the clinical isolates
was confirmed by 16S rRNA sequencing using primers 27F and
1100R [20]. Alignment analysis of 16S rRNA was performed
using T-COFFEE (available at: http://www.EMBnet.org)[21].
Wild-type (wt) Yersinia enterocolitica E40 (pYV40) and mul-
tieffector knockout mutant E40 (pIML421), commonly called
DHOPEMT, were used as control bacteria [22].
Bacterial growth condition. C. canimorsus was routinely
grown on Heart Infusion Agar (Difco) supplemented with 5%
sheep blood (Oxoid) for 2 days at 37C in an incubator con-
taining 5% CO2. Y. enterocolitica was pregrown overnight with
continuous shaking (120 rpm) in brain-heart infusion at 22C.
Before infection, the type III secretion system of Y. enterocolitica
was induced as described elsewhere [23].
Cell culture and infection. Murine monocyte-macrophage
J774.1 cells (ATCC TIB-67), human monocytic THP-1 cells
(ATCC TIB-20), and HEK293 cells (ATCC CRL-1573) were
cultured as recommended by the American Type Culture Col-
lection. Isolation and maintenance of bone marrow–derived
macrophages (BMDMs; provided by B. Combaluzier) from
C57/BI6 mice has been described elsewhere [24]. Human
monocytes were isolated from peripheral-blood mononuclear
cells using Ficoll-Paque density gradient centrifugation and
were further purified using anti-CD14 microbeads (Miltenyi
Biotec). Unless otherwise indicated, cells were seeded in me-
dium without antibiotics at a density of 105 cells/cm2 15 h before
infection. Infection was performed at 37C at an MOI of 20.
When specified, bacteria were killed by the addition of cefta-
zidime (final concentration of 10 mg/mL). For priming of J774.1
cells, cells were pretreated with interferon (IFN)–g (500 U/mL;
BD Pharmingen) for 48 h before infections. Increased respi-
ratory burst in IFN-g–primed J774.1 cells was measured using
3′-(p-aminophenyl) fluorescein, as recommended by the man-
ufacturer (Molecular Probes).
Video microscopy. J774.1 cells were placed under a Leica
DMIRE2 microscope equipped with a thermostated (37C) and
CO2-equilibrated chamber. Three-hour video sequences were
recorded using a digital camera (Hamamatsu Photonics) and
OpenLab software (version 3.1.2). Sequences were converted
to QuickTime format (Apple).
Cytokine assay. Cell-free supernatants were assayed for cy-
tokine and chemokine production using commercial ELISA kits
(BD Pharmingen) or the Bio-Plex mouse and human cytokine
multiarray system (Bio-Rad Lab).
Nitric oxide (NO) assay. NO production was estimated as
the amount of nitrite released in the culture medium, by use
of modified Griess reagent (Sigma).
Lactate dehydrogenase (LDH) release assay. LDH release
determinations were performed using the CytoTox 96 cytotox-
icity assay kit (Promega).
NF-kB assay. Human TLR2, TLR4, TLR5, MD-2, and
CD14 expression plasmids (provided by M. F. Smith, C. J.
Kirschning, and K. Miyake) have been described elsewhere [25].
Ligands for TLRs were obtained from Invivogen. HEK293 cells
were transfected in 12-well plates using Fugene 6 (Roche). Each
transfection contained 100 ng of TLR, 100 ng of MD-2, 100
ng of CD14, 500 ng of pELAM-Luc, 100 ng of pCMV–b-ga-
lactosidase, and 3 mL of Fugene 6. Transfections were cultured
for 24 h, and cells were stimulated as indicated for an additional
24 h. NF-kB activity was determined by measuring the luciferase
activity present in cell extracts. Luciferase values were nor-
malized for differences in transfection efficiency on the basis
of b-galactosidase activity in the same extracts and were ex-
pressed as fold induction values relative to the unstimulated
empty vector control.
Immunoblotting. For each experimental condition, 3106
J774.1 cells were harvested by centrifugation at 20,000 g for 5
min and resuspended in 100 mL of cell lysis buffer (20 mmol/
L Tris, 100 mmol/L NaCl, 0.2% [vol/vol] Triton X-100, and 10
mmol/L EDTA [pH 7.4]). Lysates were centrifuged at 20,000 g
for 5 min and diluted in 5 SDS/PAGE sample buffer. Samples
were boiled for 5 min, and proteins were separated on 12%
SDS/PAGE gel. Anti-p38 mitogen-activated protein kinase
(MAPK) and anti–phospho-p38 MAPK were purchased from
Cell Signaling Technology.
Reverse-transcription polymerase chain reaction (RT-PCR)
analysis. Total RNA was extracted using the RNeasy Kit (Qia-
gen). RT of RNA was performed with 1 mg of RNA, RT buffer,
0.4 mmol/L each dNTP, 40 U of RNaseOUT (Invitrogen), 8
mmol/L DTT, 500 ng of oligo(dT) primer, and 10 U of Su-
perscript II reverse transcriptase (Invitrogen) at 42C for 1 h.
PCR primer sequences are listed in table 2. The reaction
mixtures were subjected to 30 (b-actin, TLR2, and TLR4), 45
Table 1. Capnocytophaga canimorsus (Cc) strains used in this study.
Strain Collection no. Identity,a % Biological origin
Year of
isolation History and geographical origin Reference
Cc2 … 96.2 Human fatal septicemia after dog bite 1989 G. Wauters & M. Delme´e, Univ. Clinics St. Luc,
Brussels, Belgium
[9]
Cc3 … 99.0 Human septicemia 1990 G. Wauters & M. Delme´e R St. Jan Hospital,
Brugge, Belgium
[18]
Cc5 … 100 Human fatal septicemia after dog bite 1995 G. Wauters & M. Delme´e R Clinic of Libramont,
Libramont, Belgium
…
Cc7 … 99.6 Human septicemia 1998 G. Wauters & M. Delme´e R KUL, Leuven, Belgium …
Cc9 BCCM/LMG 11510, CCUG 12569, CDC A3626 100 Human septicemia 1965 BCCM/LMG R CCUG R R. Weaver, CDC, Atlanta,
Georgia R Virginia
[19]
Cc10 BCCM/LMG 11541, CCUG 17234, ATCC 35978 100 Human septicemia after dog bite … BCCM/LMG R MCCM R ATCC R R. Weaver, CDC,
Atlanta, Georgia R California Health Dept. (324-1-74)
[19]
Cc11 BCCM/LMG11551, MCCM 01373 99.1 Human septicemia … BCCM/LMG R MCCM R A. von Graevenitz, Univ. Zu¨rich,
Zu¨rich, Switzerland
…
Cc12 ATCC 35979, CDC 7120 100 Human septicemia after dog bite … ATCC R R. Weaver, CDC, Atlanta, Georgia R California
Health Dept. R San Antonio Community Hospital,
San Antonio, Texas
…
Cc13 … 99.4 Healthy dog’s (Jackie) saliva 2005 Direct isolation, Basel, Switzerland Present study
Cc14 … 100 Healthy dog’s (Pouchka) saliva 2005 Direct isolation, Basel, Switzerland Present study
NOTE. ATCC, American Type Culture Collection; BCCM/LMG, Belgian Co-ordinated Collection of Microorganisms; CCUG, Culture Collection University of Go¨teborg; CDC, Centers for Disease Control and Prevention;
KUL, Katholieke Universiteit Leuven; MCCM, Medical Culture Collection Marburg.
a Determined by comparing the 16S rRNA sequence of each strain to a reference strain (Cc12; ATCC 35979). Minimal length of 16S rRNA sequence analyzed is 300 bp.
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Table 2. Sequences of oligonucleotides used in reverse-transcription
polymerase chain reaction.
Oligonucleotide
Sequences (5′r3′)
Forward Reverse
TLR2 cagcttaaagggcgggtcagag tggagacgccagctctggctca
TLR4 agtgggtcaaggaacagaagca ctttaccagctcatttctcac
MyD88 ggatgcctggcaggggcgct gctctgtagataatcgtcag
IRAK-M gcttcggaatcgtgatc cgtgggtcttaacttggcc
SOCS-1 ttctggaaccacgtgggag caggtcctggccccagacac
b-actin taaaacgcagctcagtaacagtccg tggaatcctgtggcatccatgaaac
NOTE. IRAK, interleukin-1 receptor–associated kinase; MyD, myeloid differentiation
factor; SOCS, suppressor of cytokine signaling; TLR, Toll-like receptor.
(interleukin [IL]–1 receptor–associated kinase M [IRAK-M]),
and 35 (myeloid differentiation factor 88 [MyD88] and sup-
pressor of cytokine signaling 1 [SOCS-1]) cycles of amplication.
Statistical analysis. Results are median or val-mean SD
ues. Quantitative data were compared by use of the Mann-
Whitney U test. Differences were considered to be significant
when .P ! .05
RESULTS
Replication and survival of C. canimorsus in the presence of
J774.1 mouse macrophages. Macrophages are one of the pri-
mary mammalian defense lines against bacterial pathogens.
They not only recognize, engulf, and kill microorganisms, but
they also mobilize the antimicrobial host defense by secreting
chemokines and cytokines. We first investigated whether C.
canimorsus can survive in the presence of mouse macrophages.
We analyzed C. canimorsus–infected J774.1 macrophages by
video microscopy and observed that bacteria interacting with
macrophages were not internalized (figure 1A). In agreement
with these observations, viable count experiments showed that
C. canimorsus survive and multiply in the presence of J774.1
cells (figure 1B). Furthermore, we found that the presence of
macrophages in the cell culture medium enhanced bacterial
growth by ∼100-fold at 24 h after infection. Addition of cy-
tochalasin D had little effect on the bacterial growth rate, con-
firming that there was an insignificant level of phagocytosis.
We also monitored cytotoxicity for macrophages by measuring
LDH release. As controls, we included wt (E40 wt) and mul-
tieffector knockout (DHOPEMT) Y. enterocolitica strains. In-
terestingly, the growth of C. canimorsus did not induce cyto-
toxicity (figure 1C). Macrophages infected with C. canimorsus
remained unaltered, adherent, and viable, as examined by try-
pan blue dye exclusion (data not shown). As expected, cy-
totoxicity was observed by wt Y. enterocolitica [26] and by
DHOPEMT Y. enterocolitica [27]. Hence, C. canimorsus seems
to replicate in the presence of macrophages without inducing
cytotoxicity.
Absence of potent proinflammatory response in mouse
macrophages. To determine whether C. canimorsus infection
induces secretion of proinflammatory cytokines, J774.1 cells
were infected with 10 different strains of C. canimorsus at a 20:
1 bacteria/macrophage ratio, and culture supernatants from 24
h after infection were analyzed for the release of tumor necrosis
factor (TNF)–a and IL-1a. As shown in figure 2A, C. cani-
morsus induced only negligible amounts of TNF-a and IL-1a,
similar to those of mock-infected control cells and to those
induced by E40 wt, which prevents inflammation by injecting
YopP [28], YopE, and YopT [29] into cells. As expected, the
multieffector knockout Y. enterocolitica DHOPEMT strain ef-
fectively induced secretion of TNF-a and IL-1a [30]. Further
analysis was pursued with C. canimorsus 5 (Cc5; provided by
M. Delme´e, University of Louvain, Belgium), a strain isolated
from a patient with fatal septicemia (table 1). Production of
proinflammatory IL-6 and anti-inflammatory IL-10 by cells
infected with both live and heat-killed (HK) Cc5 was only
marginal, compared with that by mock-infected control cells
(figure 2A). To test whether this lack of cytokine release was
due to a low dose of bacteria, macrophages were exposed to
Cc5 or DHOPEMT for 2 h at various bacteria/macrophage
ratios, and supernatants from 24-h cultures were tested for
TNF-a production. Although we observed some dose depen-
dency in the response of macrophages to Cc5, the amount of
TNF-a released was significantly less than that release by
DHOPEMT-infected cells.
Priming of macrophages with IFN-g has been shown to in-
crease cellular responsiveness to inflammatory stimuli [31, 32].
To test whether primed macrophages exhibit an enhanced re-
sponse to C. canimorsus, J774.1 cells were prestimulated with
IFN-g for 48 h, infected, and analyzed for cytokines, as de-
scribed above. Surprisingly, we could not detect a significant
release of IL-1a, IL-6, or TNF-a in activated J774.1 cells in-
fected with either live or HK Cc5 (figure 2B).
We next examined the production of IL-6, IFN-g, and TNF-
a in C. canimorsus–infected BMDMs 24 h after infection. We
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Figure 1. Interaction, survival, and multiplication of Capnocytophaga canimorsus in the presence of mouse macrophages. A, J774.1 cells, infected
with C. canimorsus 5 (Cc5) (MOI of 20). After infection, 3-h video sequences were recorded. Only 1 sequence of representative images is shown.
Images were acquired at intervals of 60 s. Arrows indicate the position of the same bacterium during 4 min. Bar, 2 mm. B, J774.1 cells, infected
with Cc5 (MOI of 20). Cytochalasin D (CytD; 5 mg/mL) was added 30 min before infection and was retained during the infection. The total no. of
bacteria was determined by serial dilution and agar plating of the culture medium collected at the indicated time points. Results are representative
of 3 independent experiments. C, J774.1 cells, infected with various strains (MOI of 20) for the indicated times. Culture supernatants were collected,
and the level of lactate dehydrogenase (LDH) was measured using a CytoTox 96 assay kit. Error bars represent the SD values obtained from triplicate
samples. wt, wild type.
observed relatively moderate levels of IL-6, IFN-g, and TNF-
a on infection with either live or HK Cc5 (figure 2C). Although
levels of cytokines released on infection with Cc5 were some-
what higher than those released by infected J774.1 cells, they
were significantly lower than those released by BMDMs infected
with HK Y. enterocolitica.
No induction of a proinflammatory response in human
monocytes by C. canimorsus infection. To avoid any bias due
to host species specificity, human monocytic THP-1 cells were
infected, and culture supernatants from 6 h after infection were
analyzed for the release of IL-1b, IL-6, IL-8, IFN-g, TNF-a,
and macrophage inflammatory protein–1b. Consistent with the
weak immune responses of mouse macrophages, neither live
nor HK Cc5 induced detectable proinflammatory cytokine and
chemokine production (figure 3A). Infection with live or HK
Cc5 of human monocytes isolated from peripheral blood also
resulted in low levels of IL-8 and TNF-a (figure 3B). These
results together demonstrate that not only mouse but also hu-
man macrophages fail to trigger robust immune response to
C. canimorsus infection.
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Figure 2. Absence of tumor necrosis factor (TNF)–a, interleukin (IL)–1a, IL-6, and IL-10 release by mouse macrophages infected with Capnocytophaga
canimorsus. A, J774.1 cells, either mock infected or infected (MOI of 20) for 24 h with the indicated strains. To determine the dose response of TNF-
a release, the indicated strains were used to infect macrophages at the indicated MOIs. Bacteria were killed with ceftazidime after 2 h, and supernatants
from 24 h after infection were analyzed for TNF-a production. B, J774.1 cells, prestimulated with interferon (IFN)–g (500 U/mL) for 48 h and either
mock-infected or infected (MOI of 20) for 24 h with the indicated strains. C, Bone marrow–derived macrophages (BMDMs), infected with the indicated
strains (MOI of 20). Cell culture supernatants were collected 24 h after infection, and levels of cytokine production were analyzed by ELISA. The
results are representative of 5 independent experiments. Error bars represent the SD values. HK, heat killed; wt, wild type.
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Figure 3. Cytokine, chemokine, and nitric oxide (NO) production during Capnocytophaga canimorsus infection. A, THP-1 cells, either mock infected or infected (MOI of 20) for 6 h with the indicated
strains. Levels of interleukin (IL)–1b, IL-6, IL-8, interferon (IFN)–g, tumor necrosis factor (TNF)–a, and macrophage inflammatory protein (MIP)–1b were analyzed by ELISA. B, Human monocytes, either
mock-infected or infected (MOI of 20) for 5 h with the indicated strains. Levels of IL-8 and TNF-a were measured by ELISA. C, J774.1 and THP-1 cells and human monocytes, either mock infected or
infected (MOI of 20) with the indicated strains for 24 h, 6 h, and 5 h, respectively. Cell culture supernatants were collected, and the level of NO was determined using Griess reagent. Data are the
mean for triplicates from 5 independent experiments. Error bars represent the SD values. HK, heat killed; wt, wild type.
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Figure 4. Capnocytophaga canimorsus 5 (Cc5) interaction with Toll-like receptors (TLRs). Cc5 does not interact TLR4 or TLR5 but does interact with
TLR2. HEK293 cells were transiently transfected with NF-kB–Luc, pEF6–MD-2, pRcRSV-CD14, and either pCDNA3.1 or expression plasmids for TLR4
and TLR5 (A) or TLR2 (B). Twenty-four hours after transfection, cultures were stimulated with 1 mg/mL Escherichia coli lipopolysaccharide (LPS), 100
ng/mL Pam3CSK4, 1 mg/mL flagellin, or live or heat-killed (HK) Cc5 (MOI of 20). For inhibition of TLR4 activation by Cc5, live or HK Cc5 (MOI of 20)
and LPS were added simultaneously. Luciferase activities were determined 24 h later and were normalized to cotransfected b-galactosidase activity.
C, J774.1 cells, infected with the indicated strains (MOI of 20) or Pam3CSK4 (1 or 10 mg/mL) for 24 h. Culture supernatants were analyzed for interleukin
(IL)–6 release by ELISA. Results are values of triplicate transfections and are representative of 3 experiments performed.mean SD
Lack of detectable NO production by C. canimorsus in
mouse and human macrophages. NO is one of the primary
mediators of the host cell defense against many intracellular
and extracellular bacteria. We, therefore, assessed NO produc-
tion by C. canimorsus–infected J774.1, THP-1, and human
monocytes. Cells were infected as described above, and the
amount of NO was measured as nitrite production. Although
J774.1, THP-1, and human monocytes were capable of NO
production in response to HK or DHOPEMT Y. enterocolitica,
infection with live or HK Cc5 did not result in any detectable
NO production (figure 3C).
Lack of interaction of Cc5 with TLR4 and TLR5. TLRs
are a family of cell surface molecules that participate in innate
immune response by recognizing pathogen-associated molec-
ular patterns. Recognition and subsequent stimulation of TLRs
trigger signaling events that result in the production of proin-
flammatory cytokines [33]. We next investigated whether TLRs
are capable of recognizing C. canimorsus. To determine which,
if any, TLRs may play a role in the response of macrophages to
C. canimorsus, we examined the C. canimorsus–induced NF-kB
response of HEK293 cells transfected with TLR2, TLR4, or TLR5.
In the transfection experiment shown in figure 4, HEK293 cells
were cotransfected with the NF-kB–Luc reporter, pCMV–b-ga-
lactosidase plasmids, and either empty pcDNA3.1 vector or ex-
pression plasmids for TLR2, TLR4 (with CD14 and MD-2 ex-
pression plasmids), or TLR5. Cultures were stimulated with either
known purified TLR ligands (Pam3CSK4 for TLR2, Escherichia
coli LPS for TLR4, and Salmonella thyphimurium flagellin for
TLR5) and live or HK Cc5 for 24 h and assayed for luciferase
activity.
Cells transfected with TLR4 or TLR5 were unable to activate
NF-kB in response to C. canimorsus infection (figure 4A). The
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transfected TLR4 and TLR5 were indeed functional, as dem-
onstrated by the ability of the cells to activate NF-kB in response
to E. coli LPS or flagellin, respectively. We next tested whether
C. canimorsus can act as an antagonist of TLR4. To this end,
we stimulated transfected cells simultaneously with E. coli LPS
and live or HK Cc5. Live but not HK Cc5 prevented E. coli
LPS–induced TLR4 stimulation (figure 4A). This suggests that
C. canimorsus can indeed inhibit NF-kB activation induced by
TLR4, but this abrogation is not mediated by the antagonistic
action of its LPS.
TLR2-transfected HEK293 cells were capable of activating
NF-kB in response to live or HK Cc5 (figure 4B). To compare
the cytokine-inducing capacity of Cc5 with that of a TLR2
agonist (Pam3CSK4), we infected J774.1 cells with either live or
HK Cc5 and Pam3CSK4 (1 or 10 mg/mL) for 24 h and analyzed
the release of IL-6. As shown in figure 4B, the level of IL-6
release was significantly lower in J774.1 cells infected with either
Cc5 or HK Cc5 than with Pam3CSK4. Thus, whereas Cc5 (or
HK Cc5) could lead to NF-kB activation via TLR2, this acti-
vation did not lead to a potent inflammatory response by
macrophages.
Inhibition by Cc5 of proinflammatory response induced by
HK Y. enterocolitica. To further analyze the antagonistic ac-
tion of Cc5 on TLR4 activation, we examined whether Cc5 can
block the proinflammatory response induced by HK Y. entero-
colitica. J774.1 cells were incubated with live or HK Cc5 (MOI
of 20) in the presence or absence of HK Y. enterocolitica, and
the supernatants from 24 h after infection were tested for TNF-
a and NO release. The results shown in figure 5A clearly dem-
onstrate that there was no TNF-a or NO in the culture su-
pernatants when live but not HK Cc5 were added together with
HK Y. enterocolitica. This inhibitory effect could also be ob-
served when J774.1 cells were preinfected with live Cc5 for 24
h and then stimulated with HK Y. enterocolitica. Live Cc5, how-
ever, could not inhibit TNF-a and NO release if J774.1 cells
were prestimulated with HK Y. enterocolitica (data not shown).
Addition of cytochalasin D (5 mg/mL) during infection had no
effect on the ability of Cc5 to suppress TNF-a and NO release,
showing that internalization of C. canimorsus is not necessary
for this action (figure 5B). Release of several other cytokines
and chemokines, such as IL-3, IL-5, IL-6, IL-17, and RANTES
(data not shown), was also inhibited by live Cc5, suggesting
that the antagonistic effect of live Cc5 is global.
Regulation of TLR4 and p38 MAPK by Cc5. To determine
whether Cc5 can modulate the expression level of key molecules
involved in the production of a proinflammatory response, we
analyzed the mRNA level of TLR2, TLR4, MyD88, IRAK-M,
and SOCS-1 in J774.1 cells infected with live or HK Cc5 in the
presence or absence of HK Y. enterocolitica for 24 h by RT-PCR
(figure 5C). We found no significant change in the level of TLR2,
MyD88, IRAK-M, and SOCS-1 on infection with either live or
HK Cc5, suggesting that Cc5 does not directly regulate the ex-
pression of negative regulators, such as IRAK-M and SOCS-1,
nor of MyD88 and TLR2. In contrast, mRNA expression of TLR4
infected with live C. canimorsus was reduced. Down-regulation
in TLR4 mRNA level was not the result of C. canimorsus LPS–
induced tolerance, because HK Cc5 did not have an effect. Finally,
we assessed the activation of p38 MAPK, one of the prominent
targets of the TLR signaling cascade. The activation state of p38
MAPK was analyzed using antibody specific for its phosphory-
lated form. Infection of J774.1 cells with live Cc5 for 24 h resulted
in complete dephosphorylation of p38, whereas HK Cc5 had no
effect. Cc5 infection did not alter the level of total p38 (figure
5D). It is interesting to note that suppression of p38 phosphoryla-
tion by live Cc5 coincided with the inhibition of inflammatory
responses as well as the down-regulation of TLR4.
DISCUSSION
The clinical overview of C. canimorsus infections hints at the
ability of the bacterium to avoid the immune system, at least
in the early stages of the infection. To this end, we characterized
the immune response from mouse and human macrophages
on C. canimorsus infection. We found that C. canimorsus does
not activate signals leading to the release of proinflammatory
cytokines, chemokines, and NO. This confirms and extends a
previous report that normal whole blood produces lower levels
of IL-1b and IL-6 in response to C. canimorsus than in response
to other gram-negative bacteria [34]. Both mouse and human
macrophages were unable to produce potent proinflammatory
responses on infection with either live or HK C. canimorsus.
Our data thus suggest relatively silent entry of C. canimorsus
into the host, where it replicates and survives in the presence
of macrophages. We did not observe any cytotoxicity by the
10 strains of C. canimorsus for macrophages. This result is at
odds with the data from Fischer et al. [12], especially because
the strain used in this previous study was included in our
experiments [12]. At this time, we have no explanation for this
discrepancy.
Why are macrophages unable to mediate proinflammatory
responses against C. canimorsus? We found that one of the
immune sensors of invading pathogens, TLR4, is unable to
activate NF-kB on encountering either live or HK C. canimorsus.
This suggests that the lipid A moiety of C. canimorsus LPS may
be different from that of the enteric bacteria, for example, in
its acylation pattern [35]. Further investigation on the structure
of C. canimorsus LPS is under way, to determine its structure
and to characterize its endotoxic activity. Although C. cani-
morsus does not react with TLR4, it interacts with TLR2. Ac-
tivation of TLR2 by C. canimorsus, however, does not seem to
result in a potent proinflammatory response. Further investi-
gation of the functional role of TLR2 activation, as well as
identification of the TLR2 ligand from C. canimorsus, is needed.
Figure 5. Inhibition of heat-killed (HK) Yersinia enterocolitica–induced proinflammatory response by Capnocytophaga canimorsus 5 (Cc5). A, J774.1
cells, infected with the indicated strains (MOI of 20) together with or without HK E40 (MOI of 20) for 24 h. Culture supernatants were analyzed for
the release of nitric oxide and tumor necrosis factor (TNF)–a. B, J774.1 cells, infected as in panel A, in the presence of cytochalasin D (CytD) at 5
mg/mL. C, J774.1 cells, amplified by polymerase chain reaction (PCR). After infection of J774.1 cells with the indicated strains (MOI of 20) for 24 h,
total RNA was extracted, reverse transcribed, and amplified by PCR. The PCR products were separated in 1.2% agarose gel. D, J774.1 cells, infected
with the indicated strains (MOI of 20) for 24 h. After infection, cell lysates were prepared and separated on a 12% SDS-PAGE gel. Immunoblotting
was performed using an antibody specific for the phosphorylated form of p38 (p-p38) and total p38. IRAK-M, interleukin-1 receptor–associated kinase
M; MyD88, myeloid differentiation factor 88; SOCS-1, suppressor of cytokine signaling 1.
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We further provide evidence that NO, TNF-a, and other
proinflammatory cytokines are absent from the culture super-
natant of macrophages when stimulated by HK Y. enterocolitica
in the presence of live C. canimorsus. Live Cc5 could degrade
and/or prevent the release of NO and cytokines produced by
macrophages through interference with the proinflammatory-
signaling cascade. We favor the second interpretation for 2
reasons. First, it would be unlikely that Cc5 would degrade NO
and all tested cytokines. Second, infection of live Cc5 leads to
complete dephosphorylation of p38 MAPK, whereas HK Cc5
does not. Down-regulation of p38 MAPK activation correlates
well with its critical role in cytokine production, phagocytosis,
and regulation of CD14, TLR2, and TLR4 expression [36–40].
Clearly, this active anti-inflammatory response of C. canimorsus
raises a number of questions that need to be addressed: what
signaling pathways are targeted and by what kind of toxin or
effector? It is striking to note that other pathogens, such as
Ehrlichia chaffeensis [39], Francisella tularensis [41], Listeria
monocytogenes [42], and Leishmania donovani [43], also down-
regulate the inflammatory cascade through p38 inhibition.
Whether these targets are modulated by common mechanisms
or by similar effectors is yet to be determined.
C. canimorsus is a commensal of dogs’ and cats’ mouths.
Recent observations have shown that commensal bacteria often
do not trigger an inflammatory response but instead, in some
cases, have the capacity to actively turn it down. Hence, com-
mensals may be viewed as regulatory quenchers of the inflam-
mation, preventing the progression from the acute to the
chronic state [44]. In conclusion, C. canimorsus possesses both
passive and active mechanisms of immune evasion. It is likely
that the passive mechanism involves the escape of TLR4 de-
tection through a unique LPS structure. Although it remains
unclear how C. canimorsus antagonizes TLR4 activation by the
active mechanism, it seems to target critical players that are
also manipulated by other pathogens. A better understanding
of this mechanism could lead not only to the prevention of
these dramatic infections but also to a better understanding of
the regulation of the innate immune system.
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